Status:
COMPLETED
Comparison of PRISM III, PIM2 and PELOD Scoring Systems
Lead Sponsor:
Antalya Training and Research Hospital
Collaborating Sponsors:
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
Haydarpasa Numune Training and Research Hospital
Conditions:
Congenital Heart Disease
Eligibility:
All Genders
1-18 years
Brief Summary
PRISMIII(Pediatric Risk of Mortality III), PIM2(Pediatric Index of Mortality 2) and PELOD(Pediatric Logistic Organ Dysfunction) are frequently used for predicting mortality and morbidity in general pe...
Eligibility Criteria
Inclusion
- Patients younger than 18 years of age who had undergone congenital heart surgery
Exclusion
- emergency operations Patients staying in intensive care unit for less than 24 hours
Key Trial Info
Start Date :
February 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2019
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT04848168
Start Date
February 1 2019
End Date
May 1 2019
Last Update
September 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
siyami ersek TRH
Istanbul, Turkey (Türkiye)